Want to see IN:HCG full AI Analyst Report?
HealthCare Global Enterprises Ltd. (HCG) Ratios
HealthCare Global Enterprises Ltd. Ratios
IN:HCG's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:HCG's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.12 | 0.81 | 0.91 | 1.02 | 1.07 |
| Quick Ratio | 1.06 | 0.76 | 0.86 | 0.95 | 1.01 |
| Cash Ratio | 0.53 | 0.23 | 0.37 | 0.31 | 0.42 |
| Solvency Ratio | 0.10 | 0.07 | 0.09 | 0.09 | 0.11 |
| Operating Cash Flow Ratio | 0.34 | 0.30 | 0.38 | 0.44 | 0.47 |
| Short-Term Operating Cash Flow Coverage | 1.12 | 0.80 | 1.52 | 6.69 | 4.92 |
| Net Current Asset Value | $ -13.77B | $ -17.09B | $ -11.63B | $ -8.66B | $ -8.33B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.44 | 0.52 | 0.47 | 0.39 | 0.41 |
| Debt-to-Equity Ratio | 1.30 | 1.99 | 1.54 | 1.05 | 1.05 |
| Debt-to-Capital Ratio | 0.57 | 0.67 | 0.61 | 0.51 | 0.51 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.40 | 0.37 | 0.30 | 0.29 |
| Financial Leverage Ratio | 2.94 | 3.84 | 3.28 | 2.69 | 2.55 |
| Debt Service Coverage Ratio | 0.91 | 0.55 | 0.84 | 1.55 | 0.94 |
| Interest Coverage Ratio | 1.26 | 7.17 | 9.91 | 8.65 | 7.74 |
| Debt to Market Cap | 0.12 | 0.14 | 0.14 | 0.11 | 0.12 |
| Interest Debt Per Share | 134.78 | 143.07 | 98.74 | 71.81 | 77.73 |
| Net Debt to EBITDA | 2.68 | 5.12 | 3.75 | 3.06 | 4.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 51.10% | 53.58% | 54.78% | 54.28% | 53.80% |
| EBIT Margin | 8.02% | 8.01% | 8.13% | 8.00% | 5.69% |
| EBITDA Margin | 17.64% | 14.08% | 13.97% | 14.00% | 12.76% |
| Operating Profit Margin | 8.73% | 49.85% | 51.52% | 49.76% | 51.85% |
| Pretax Profit Margin | 1.06% | 2.56% | 3.54% | 2.65% | 6.28% |
| Net Profit Margin | 0.54% | 2.00% | 2.52% | 1.73% | 3.84% |
| Continuous Operations Profit Margin | 0.90% | 2.20% | 2.16% | 1.04% | 2.78% |
| Net Income Per EBT | 51.11% | 77.96% | 71.10% | 65.39% | 61.22% |
| EBT Per EBIT | 12.15% | 5.14% | 6.88% | 5.32% | 12.11% |
| Return on Assets (ROA) | 0.35% | 1.25% | 1.78% | 1.27% | 2.42% |
| Return on Equity (ROE) | 1.03% | 4.81% | 5.83% | 3.41% | 6.17% |
| Return on Capital Employed (ROCE) | 7.63% | 44.38% | 50.17% | 48.30% | 41.42% |
| Return on Invested Capital (ROIC) | 5.71% | 32.15% | 27.40% | 18.08% | 17.51% |
| Return on Tangible Assets | 0.39% | 1.45% | 1.96% | 1.39% | 2.68% |
| Earnings Yield | 0.18% | 0.60% | 1.03% | 0.80% | 1.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.99 | 5.51 | 6.49 | 5.60 | 5.83 |
| Payables Turnover | 3.54 | 3.09 | 3.08 | 3.12 | 3.33 |
| Inventory Turnover | 20.75 | 19.46 | 20.26 | 20.23 | 21.54 |
| Fixed Asset Turnover | 1.23 | 1.12 | 1.18 | 1.24 | 1.03 |
| Asset Turnover | 0.65 | 0.63 | 0.71 | 0.73 | 0.63 |
| Working Capital Turnover Ratio | -60.03 | -16.68 | -71.03 | 79.54 | 1212.30 |
| Cash Conversion Cycle | -24.65 | -33.21 | -44.39 | -33.86 | -30.04 |
| Days of Sales Outstanding | 60.98 | 66.27 | 56.26 | 65.16 | 62.65 |
| Days of Inventory Outstanding | 17.59 | 18.75 | 18.01 | 18.04 | 16.94 |
| Days of Payables Outstanding | 103.22 | 118.24 | 118.66 | 117.06 | 109.63 |
| Operating Cycle | 78.56 | 85.03 | 74.27 | 83.20 | 79.59 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 24.47 | 22.78 | 20.45 | 18.09 | 16.97 |
| Free Cash Flow Per Share | 3.88 | 7.77 | 7.11 | 8.51 | 11.48 |
| Dividend Paid and CapEx Coverage Ratio | 1.19 | 1.52 | 1.53 | 1.89 | 3.09 |
| Capital Expenditure Coverage Ratio | 1.19 | 1.52 | 1.53 | 1.89 | 3.09 |
| Operating Cash Flow Coverage Ratio | 0.20 | 0.17 | 0.22 | 0.28 | 0.24 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.14 | 0.15 | 0.15 | 0.16 |
| Free Cash Flow Yield | 0.74% | 1.47% | 2.11% | 3.24% | 4.25% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 541.44 | 165.92 | 97.34 | 124.37 | 65.15 |
| Price-to-Sales (P/S) Ratio | 2.93 | 3.31 | 2.45 | 2.15 | 2.50 |
| Price-to-Book (P/B) Ratio | 5.59 | 7.99 | 5.68 | 4.24 | 4.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 135.46 | 68.08 | 47.40 | 30.84 | 23.51 |
| Price-to-Operating Cash Flow Ratio | 21.46 | 23.24 | 16.47 | 14.51 | 15.90 |
| Price-to-Earnings Growth (PEG) Ratio | -7.78 | -21.26 | 1.52 | -2.54 | -0.52 |
| Enterprise Value Multiple | 19.32 | 28.66 | 21.30 | 18.45 | 23.64 |
| Enterprise Value | 86.50B | 89.70B | 56.89B | 43.77B | 42.18B |
| EV to EBITDA | 19.32 | 28.66 | 21.30 | 18.45 | 23.64 |
| EV to Sales | 3.41 | 4.04 | 2.98 | 2.58 | 3.02 |
| EV to Free Cash Flow | 157.26 | 82.87 | 57.52 | 36.98 | 28.33 |
| EV to Operating Cash Flow | 24.92 | 28.29 | 19.99 | 17.40 | 19.16 |
| Tangible Book Value Per Share | 69.77 | 36.72 | 44.01 | 48.14 | 51.86 |
| Shareholders’ Equity Per Share | 93.90 | 66.26 | 59.35 | 61.88 | 67.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.14 | 0.39 | 0.61 | 0.56 |
| Revenue Per Share | 178.94 | 159.67 | 137.43 | 121.84 | 107.76 |
| Net Income Per Share | 0.97 | 3.19 | 3.46 | 2.11 | 4.14 |
| Tax Burden | 0.51 | 0.78 | 0.71 | 0.65 | 0.61 |
| Interest Burden | 0.13 | 0.32 | 0.44 | 0.33 | 1.10 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.04 | 0.01 | 0.03 | 0.01 |
| Stock-Based Compensation to Revenue | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 12.89 | 5.57 | 4.20 | 5.61 | 2.51 |
Currency in INR
